Cancellation · USPTO

Cancellation 92031175

OtherUSPTO

Cancellation 92031175 at USPTO between Teva Pharmaceutical Industries, Ltd. and Solvay Pharmaceuticals Marketing & Licensing AG By Change of Name From Dutraco S.A., over the mark TEVETEN, filed Sep 8, 2000. Status in the office record: other.

View TEVETENGet this data via the API
Status
Other
Result
Other
Filed
Sep 8, 2000
Marks involved
2
Parties

Who is involved

The parties as named in the office record.

Petitioner

Teva Pharmaceutical Industries, Ltd.

Company trademarks
Respondent

Solvay Pharmaceuticals Marketing & Licensing AG By Change of Name From Dutraco S.A.

Timeline

How the case has moved

Dates from the USPTO record and the TEVETEN filing.

  1. TEVETEN filed

    Application 74721045 filed at the USPTO.

  2. TEVETEN registered

  3. Cancellation filed

    Teva Pharmaceutical Industries, Ltd. started cancellation 92031175 at USPTO against TEVETEN.
Marks

Marks involved

1 contested mark, 1 mark the challenger relies on.

MarkRoleApplicationOffice
TEVETENContested74721045USPTO
TEVARelied on73781811USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_e0514cb3-da2f-4702-bbcb-183efd505855
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_e0514cb3-da2f-4702-bbcb-183efd505855",
  "object": "proceeding",
  "proceeding_type": "cancellation",
  "proceeding_number": "92031175",
  "status": "other",
  "office_code": "US",
  "filed_date": "2000-09-08",
  "parties": [
    {
      "name": "TEVA PHARMACEUTICAL INDUSTRIES, LTD.",
      "role": "petitioner"
    },
    {
      "name": "SOLVAY PHARMACEUTICALS MARKETING & LICENSING AG BY CHANGE OF NAME FROM DUTRACO S.A.",
      "role": "respondent"
    }
  ]
}